The Dietary Supplement Health and Education Act of 1994, usually called DSHEA, is the law that shaped the modern U.S. supplement market. For founders, DSHEA is not just legal history. It explains why supplements are regulated differently from drugs, why labels use Supplement Facts panels, why certain claims require disclaimers, why new dietary ingredient questions matter, and why manufacturing quality systems are central to a responsible launch.

For a supplement founder, the practical question is not just what the law says in abstract. It is how those rules affect formula planning, supplier qualification, label copy, launch timing, ecommerce pages, retailer onboarding, and the way your manufacturing partner documents every batch. NutraCap Labs helps brands move through those steps with USA-made manufacturing support, cGMP-oriented systems, low minimum order quantities, in-house design help, warehousing, fulfillment, and a direct-to-manufacturer path that avoids unnecessary middlemen.

What DSHEA did

DSHEA amended the Federal Food, Drug, and Cosmetic Act and became Public Law 103-417 on October 25, 1994. It created a specific federal framework for dietary supplements, including definitions, safety and adulteration standards, labeling rules, claims provisions, new dietary ingredient requirements, and the authority to establish good manufacturing practice rules for the category. It also helped establish the Office of Dietary Supplements within the National Institutes of Health.

The law treats dietary supplements generally as a category of food, not as drugs, unless a product’s ingredients, intended use, or claims move it into another regulatory category. That distinction is why dietary supplements do not go through the same premarket approval pathway as drugs. It is also why responsible brands must understand the boundaries: DSHEA created market access, but it did not create a free-for-all.

Definition of a dietary supplement

Under DSHEA, a dietary supplement is intended to supplement the diet and contains one or more dietary ingredients such as a vitamin, mineral, herb or other botanical, amino acid, dietary substance for use by humans to supplement the diet, or a concentrate, metabolite, constituent, extract, or combination of those ingredients. It must be intended for ingestion and not represented as a conventional food or as the sole item of a meal or diet. It also must be labeled as a dietary supplement.

That definition affects product development from day one. A capsule, powder, gummy, liquid, tablet, softgel, or bar may fit the category depending on its intended use and labeling. A topical cream, inhaled product, or product marketed to cure a disease may not. Before founders invest in packaging or claims, they should confirm that the product concept fits the dietary supplement lane.

FDA authority under DSHEA

DSHEA did not require FDA to approve most dietary supplements before sale. FDA states that it does not have authority to approve supplements for safety and effectiveness before they are marketed, and it generally does not approve labels or claims before use. Instead, the company is responsible for ensuring the product is safe, properly labeled, not adulterated, and not misbranded. FDA can inspect, monitor the marketplace, review regulatory submissions, and act against violative products after they enter commerce.

For brand owners, that means compliance must be built into the launch process. Waiting for an outside agency to catch mistakes is not a strategy. The brand needs ingredient documentation, supplier qualification, label review, claim substantiation, manufacturing records, complaint procedures, and a plan for adverse event reporting where applicable.

Claims and the DSHEA disclaimer

DSHEA established special requirements for certain dietary supplement labeling claims. Structure/function claims can describe the role of a nutrient or dietary ingredient intended to affect normal structure or function, or how it acts to maintain such structure or function. General well-being claims and certain nutrient deficiency disease claims also fall under the dietary supplement claims framework.

These claims require substantiation that they are truthful and not misleading. They also require the familiar disclaimer when used in dietary supplement labeling: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” FDA notification is required no later than 30 days after first marketing the supplement with certain 403(r)(6) claims. The disclaimer and notification do not authorize disease claims. A product promoted to diagnose, treat, cure, mitigate, or prevent disease can be regulated as a drug.

New dietary ingredients

DSHEA created the new dietary ingredient concept. A new dietary ingredient is generally a dietary ingredient that was not marketed in the United States before October 15, 1994. In many situations, a company must submit a notification to FDA at least 75 days before marketing a product containing an NDI, unless an exception applies. The notification is about safety information for the ingredient under the proposed conditions of use; it is not a finished product approval.

From a buyer-journey perspective, this is why ingredient screening should happen before flavor work, label design, and purchase orders. If an NDI question appears late, launch timing can change. A manufacturer with formulation and quality experience can help identify questions early, but brands should involve qualified regulatory counsel for legal conclusions.

Good manufacturing practices

DSHEA authorized dietary supplement good manufacturing practice rules, and those rules are now found in 21 CFR Part 111. They cover firms that manufacture, package, label, or hold dietary supplements. The regulations require systems for specifications, production and process controls, quality control review, testing, master manufacturing records, batch production records, packaging and labeling controls, reserve samples, complaints, and recordkeeping.

In everyday terms, cGMP is how a brand proves that the product in the bottle matches the formula, label, and quality expectations. It is also how the brand and manufacturer trace issues if a raw material, label, batch, or customer complaint needs investigation. When founders compare manufacturers, price per bottle should not be the only question. Ask how batches are documented, how labels are controlled, how ingredients are qualified, how finished products are released, and how records are retained.

What DSHEA means for private label and custom brands

For a private label launch, DSHEA-related questions include whether the formula fits the supplement category, whether claims are appropriate for the existing formula, whether the label includes required elements, and whether production occurs under suitable controls. Private label can move faster because the formula path is clearer, but speed should not mean skipping claim and label review.

For a custom formula, DSHEA considerations start even earlier. Ingredient selection, serving size, delivery form, flavor system, excipients, allergen concerns, NDI status, and claims all interact. A great brand idea can become difficult to launch if it depends on an ingredient with unclear regulatory status or claim language that overpromises. NutraCap Labs can help founders compare options, work through custom formulation and R&D, plan packaging, and coordinate in-house label design with manufacturing realities.

Founder checklist

Use DSHEA as a practical checklist: Is the product truly a dietary supplement? Are all dietary ingredients understood and documented? Is there any new dietary ingredient question? Are claims structure/function or general wellness rather than disease treatment claims? Is the required disclaimer included where needed? Has the team planned FDA claim notification timing? Does the label include the required Supplement Facts and business information? Is the manufacturer operating with cGMP-oriented controls? Are records organized for every batch?

Answering those questions early helps a brand avoid expensive relabeling, delayed retailer onboarding, rejected marketplace listings, and compliance stress after launch. DSHEA gave supplement founders a path to market. The brands that use that path well are the ones that pair opportunity with disciplined formulation, documentation, labeling, and quality systems.

Ready to build a compliant supplement launch plan?

Whether you are starting with a private label formula or developing a custom product from scratch, the safest path is to involve manufacturing, quality, and labeling conversations early. NutraCap Labs can help you review product form, ingredient direction, packaging, label design, production requirements, and fulfillment needs before you invest in inventory.

Ready to launch your supplement brand? Get a free quote from NutraCap Labs.

Questions to ask before the first purchase order

Before approving a quote, ask who owns formula decisions, who reviews the final label, what documentation will be available for each lot, how packaging components are checked, how changes are approved, what lead times apply to samples and production, and whether fulfillment can be coordinated after manufacturing. These operational details turn regulatory concepts into a launch plan. They also help a founder compare a direct manufacturer with a broker who may not control the facility, quality system, or production calendar.

NutraCap Labs works with supplement entrepreneurs who need both education and execution. The process can include private label formula selection, custom formulation and R&D, low-MOQ production planning, label and graphic design, packaging decisions, warehousing, and shipping support. The result is not a guarantee of sales or regulatory immunity; it is a clearer, more documented path from idea to finished product.

How to brief your manufacturer

A strong manufacturer brief should include the target delivery form, desired serving size, ingredient preferences, ingredients to avoid, flavor direction, packaging preference, estimated first order quantity, launch channel, label deadline, and any required retailer documentation. Include claims you are considering, but mark them as draft until they have been reviewed. That gives the formulation, quality, and label teams a chance to identify issues before bottles, pouches, labels, or cartons are ordered.

For startups, this brief prevents wasted quoting cycles. For scaling brands, it keeps procurement, marketing, compliance, and operations aligned. It also helps NutraCap Labs recommend whether a private label option, modified stock formula, or custom R&D path best fits the timeline and budget.

Documentation that protects the brand later

Compliance work should leave a paper trail. Keep final label files, formula specifications, supplier documents, batch numbers, lot-specific records, finished product release documentation, claim substantiation files, and copies of marketplace or retailer submissions. If a consumer question, retailer request, platform review, or regulatory inquiry appears later, organized records can shorten the response and reduce confusion.

This is one reason direct manufacturing relationships matter. When records sit with the actual facility instead of several disconnected intermediaries, the brand has a clearer path to answers about what was produced, when it was produced, how it was checked, and which packaging and label components were used.